Friday, June 17, 2022 Daily Archives

CBM accelerates plans to add capacity for 10,000 patient therapies

by

The Center for Breakthrough Medicines (CBM) and Discovery Labs respond to the critical shortage of cell therapies by accelerating plans to build capacity to produce over 10,000 patient therapies. The plant expansion at CBM’s King of Prussia, Philadelphia, which was initially outlined to begin planning in 2024-2025, has now been started due to “the critical lack of cell therapy supply,” a spokesperson for CBM told us. “We are also seeing shortages for already approved products, long waitlists, and doctors being…

June 17, 2022

MilliporeSigma and Agilent aim to extend PAT to real-time release

by

Merck Life Science (AKA MilliporeSigma) and Agilent Technologies have teamed up to develop process analytical technologies (PAT), citing growing drug industry demand for systems that support real-time release. The collaboration will combine the German drug maker known as MilliporeSigma in North America and the Life Science business of Merck KGaA elsewhere bioprocessing technologies with Agilent’s analytical systems to extend “real-time monitoring and automated process control of critical process parameters (CPPs) and critical quality attributes (CQAs) to downstream processing” the firms…

June 17, 2022